Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous02.06.2021 / 07:00 Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration Geneva, Switzerland, Ju.
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Personnel28.05.2021 / 07:00 Relief Appoints Dr. Taneli Jouhikainen as Chief Operating OfficerGeneva, Switzerland, May 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lea.
Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Search jobs 25-May-2021 Relief s Partner Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous
25.05.2021 / 07:00
Relief s Partner Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
Newton, MA, USA and Geneva, Switzerland, May 25, 2021 - Acer Therapeutics Inc. (Nasdaq: ACER)( Acer ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF)( Relief ), a biopharmaceutical company with its lead compound RLF-100